Tudor Investment Corp
AKCA

Tudor Investment Corp’s Akcea Therapeutics Inc AKCA Stock Holding History

Tudor Investment Corp’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,228
Closed -$313K – 1763
2020
Q3 		$313K Sell
17,228
-8,181
-32% -$116K 0.01% 968
2020
Q2 		$348K Sell
25,409
-2,955
-10% -$45.6K 0.02% 836
2020
Q1 		$406K Sell
28,364
-18,069
-39% -$297K 0.04% 572
2019
Q4 		$787K Buy
46,433
+3,973
+9% +$73.9K 0.04% 581
2019
Q3 		$653K Buy
42,460
+11,790
+38% +$251K 0.02% 631
2019
Q2 		$719K Buy
+30,670
New +$758K 0.02% 593

Tudor Investment Corp's AKCA Position: Q4 2020 in Review

Tudor Investment Corp sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 17,228 shares — an estimated $313K sold.

Tudor Investment Corp first reported a position in AKCA in Q2 2019 and held it in 6 quarters. The position peaked at $787K in Q4 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Tudor Investment Corp reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 17,228 Akcea Therapeutics Inc shares in Q4 2020, an estimated $313K.
  • Tudor Investment Corp first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 6 quarters.
  • Tudor Investment Corp's Akcea Therapeutics Inc position peaked at $787K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Tudor Investment Corp's 13F filing for Q4 2020, filed 16 Feb 2021.